Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : KDUS, who knows this company? -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (96)	2/4/1998 3:35:00 PM
From: Dave K	Read Replies (1) \| Respond to of 117

Sorry, I need to rub some salt in that wound :-). Finally got around to calling the company just as the fireworks started this a.m.. Something I seriously regret not doing sooner. Jennifer LaVin represents what should be the standard for I.R. relations. Few notes and lessons I think we should all learn: 1. The company is on track, just as SVogel told us all a few days ago. 2. As of today, the key scientists and management are very much intact. 3. Do not discount the M.I.T collaboration. 4. Do not discount Axiom. 5. Do not discount SKB just yet. The board will make the decision ahead. 6. Patent issue: Read the 10K statement. It still stands as it has. 7. My big lesson for the day: Finally, do not make or pay attention to wild speculations about a company. Instead, call I.R. to get the facts. 8. Traders and hedgers will dump their stock on any negative news as they don't have a clue as to the fundamentals. The smart folks were simply waiting. P.S.(Off Topic) Another company with excellent I.R. is Ann at Aquila Biopharmaceuticals. Cheers! Dave

To: scaram(o)uche who wrote (96)	4/14/1999 8:45:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 117

Wednesday April 14, 8:07 am Eastern Time Company Press Release Axiom Biotechnologies Licenses High-Speed Flow Cytometry Fluidics Handling Technology From University of New Mexico SAN DIEGO--(BW HealthWire)--April 14, 1999--Axiom Biotechnologies Inc. today announced that the company has entered into an exclusive, long-term license agreement with the Science & Technology Corp. @ UNM for a novel fluidics technology, Plug-Flow Cytometry (PFC), that dramatically accelerates the sampling rates and throughput capabilities of flow cytometry. (snip)